Article

Wilmer, Bascom Palmer prevail in annual survey

This year's Ophthalmology Times Best Programs Survey shows that, although the very best programs are almost universally recognized, it's not the size that matters. Some smaller programs are starting to draw the attention of department chairpersons across the United States.

Key Points

Given the number of outstanding U.S. ophthalmology programs, staying at the head of the class requires innovation, a top-to-bottom commitment to excellence, and a willingness to adapt to changing needs, ideas, and technology.

This year's Ophthalmology Times Best Programs Survey shows that, although the very best programs are almost universally recognized, it's not the size that matters. Some smaller programs are starting to draw the attention of department chairpersons across the United States.

Learning from others

After more than a decade of recognition as one of the country's leading ophthalmology programs, the Wilmer Eye Institute is not one to rest on its laurels. Peter J. McDonnell, MD, director and William Holland Wilmer Professor of Ophthalmology at the institute, said he is constantly observing other schools and searching for ways to stay on top.

Such determination pushes his faculty and staff to compete with themselves and always strive to improve. Reflecting that effort, the institute is one of three in the top 10 that is in "building mode." The Wilmer Eye Institute broke ground June 6 on a $108 million, 207,000-square-foot building that Dr. McDonnell believes will house the most modern ophthalmic surgical facility and vision research center in the world.

The new building is designed to encourage interaction among scientists, with laboratories for colleagues from different science backgrounds-each tackling a disease from a unique perspective working in common "research neighborhoods."

"It's no longer a brilliant person sitting in an office or lab thinking of great ideas," he said. "It's teams working together to make the breakthroughs."

Such collaboration will be encouraged with pathways through the building designed to encourage informal conferences as researchers bump into colleagues on the way to the coffee shop. The building is expected to be complete in June 2009.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.